Tech Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.

Press releases published on September 9, 2026

Sep. 9, 2026

Human Centered Holdings applies to steward .human

Indeterminate GlobeNewswire

Sep. 9, 2026

Peapack Private Expands Specialty Lending Capabilities with Launch of Yacht Financing Business

Indeterminate GlobeNewswire

Sep. 9, 2026

PageUp Achieves ISO/IEC 42001:2023 Certification for Artificial Intelligence Management Systems

Indeterminate GlobeNewswire

Sep. 9, 2026

SASE OpsLab Ltd Appoints Cybersecurity Veteran Franck Burtin as Chief Revenue Officer to Drive Global SASE Automation Expansion

Indeterminate GlobeNewswire

Sep. 9, 2026

Presentations.ai Slide Generator for Investor Pitch Decks and Sales PPT's 2026 Update - 12 Million Users Trust The AI Powerpoint Maker To Automate and Scale Professional AI Slide Generation With Branding, Design and Data

Indeterminate GlobeNewswire

Sep. 9, 2026

Forward Industries Urges Shareholders of SkyAI to Vote No at the 2026 Annual Meeting

Indeterminate GlobeNewswire

Sep. 9, 2026

HIZERO Takes an Exciting Leap Forward at IFA 2026, Sparking a Surge of Interest in Its Broadened No Suction Technology™ Range

Indeterminate GlobeNewswire

Sep. 9, 2026

Trethera Congratulates Board Director Dr. Timothy R. Donahue on Appointment to Senior Leadership Roles at Weill Cornell Medicine and NewYork-Presbyterian

Indeterminate GlobeNewswire

Sep. 9, 2026

2026 Kantar BrandZ Top 100 Most Valuable Chinese Brands unveiled: seven new entrants join the ranking as total brand value grows by 13%

Indeterminate GlobeNewswire

Sep. 9, 2026

OSE Immunotherapeutics Welcomes First Patient Dosed by Veloxis in the Phase 2 RENGEVITY-201 Trial Evaluating Pegrizeprument (VEL-101) for the Prevention of Organ Rejection in Kidney Transplant Recipients

Indeterminate GlobeNewswire

Sep. 9, 2026

OSE Immunotherapeutics se félicite de l’inclusion du premier patient traité par Veloxis dans l’étude de phase 2 RENGEVITY-201 évaluant le pegrizeprument (VEL-101) dans la prévention du rejet d’organe chez les patients transplantés rénaux

Indeterminate GlobeNewswire

Sep. 9, 2026

Bronstein, Gewirtz & Grossman LLC Urges Hyliion Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm

Indeterminate GlobeNewswire

Sep. 9, 2026

Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Indeterminate GlobeNewswire

Sep. 9, 2026

Bronstein, Gewirtz & Grossman LLC Urges Cogent Communications Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Indeterminate GlobeNewswire

Sep. 9, 2026

Bronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Indeterminate GlobeNewswire

Sep. 9, 2026

Bronstein, Gewirtz & Grossman LLC Urges Park Ha Biological Technology Co., Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

Indeterminate GlobeNewswire

Sep. 9, 2026

Carahsoft and Sonar Expand Partnership to Deliver AI Code Verification and Governance Across All North American Markets

Indeterminate GlobeNewswire

Sep. 9, 2026

Verizon declares quarterly dividend on September 9, 2026

Indeterminate GlobeNewswire

Sep. 9, 2026

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Centerspace (NYSE – CSR), Fulcrum Therapeutics, Inc. (Nasdaq – FULC), Weave Communications, Inc. (NYSE – WEAV), Bio-Techne Corporation (Nasdaq – TECH)

Indeterminate GlobeNewswire

Sep. 9, 2026

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Eagle Financial Services, Inc. (Nasdaq: EFSI), Safety Insurance Group, Inc. (Nasdaq – SAFT), Utz Brands, Inc. (NYSE – UTZ), Distribution Solutions Group, Inc.…

Indeterminate GlobeNewswire